Overview

A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

Status:
Not yet recruiting
Trial end date:
2028-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether APG-157 can reduce the tumor size in participants with the study disease. Another purpose is to find out about the effects of APG-157 on certain tumor markers and oral rinses in participants with the study disease.
Phase:
Phase 2
Details
Lead Sponsor:
Elizabeth J Franzmann
Collaborator:
Aveta Biomics, Inc.